Tuesday, May 24, 2022

We May Never Know If Covid Leaked From A Lab Unless The United States Stops Helping China Cover Up The Truth; Unvaccinated cadets will graduate, but won’t receive commissions, Air Force Academy says, and other C-Virus related stories

Daily Mail / YouTube
We May Never Know If Covid Leaked From A Lab Unless The United States Stops Helping China Cover Up The Truth:
Whether lab or market origin, anyone trying to cover for China should remember both scenarios are humiliating for the Chinese government
The only Covid narrative that doesn’t directly aim to control people has to do with determining the origin of SARS-CoV-2. Discovering the origin of the virus should have been a top priority, but it was not. Why? Perhaps, instead of controlling people, the goal in this case was to cover for complicit behavior.
There are only two plausible competing virus origin hypotheses: “lab leak” and “wet market.” Instead of imploring scientists to work together and discover the truth, then-National Institutes of Health Director Francis Collins wrote in an email to presidential medical advisor Anthony Fauci early in the pandemic: “Wondering if there is something NIH can do to help put down this very destructive conspiracy [i.e., ‘lab leak’], with what seems to be growing momentum.”
Knowing that SARS-CoV-1 leaked from a Chinese lab on at least two occasions in the early 2000s, why would Collins and Fauci be so quick to “put down” the lab leak hypothesis?
Evidence Wuhan Lab Was Doing Risky Experiments
A 2016 publication in the premier journal PNAS entitled “SARS-like WIV1-CoV poised for human emergence” gave us more than enough evidence that risky experiments were being conducted at the Wuhan Institute of Virology. Specifically, the authors stated: “This manuscript describes efforts to extend surveillance beyond sequence analysis, constructing chimeric and full-length zoonotic coronaviruses to evaluate emergence potential” (emphasis mine).
In other words, the authors were creating novel viruses and determining how well they could infect human cells. A curious feature of SARS-CoV-2 is the presence of a furin cleavage site in its spike protein that gives it remarkable infectivity. Human cells display a specialized enzyme called “furin protease” that can cleave the SARS-CoV-2 spike protein at the furin cleavage site to facilitate efficient infection. --->READ MORE HERE
Chancey Bush/The Gazette via AP, File
Unvaccinated cadets will graduate, but won’t receive commissions, Air Force Academy says:
Three U.S. Air Force Academy cadets whose refusal to get COVID-19 vaccines threatened their May 25 graduation — along with the risk of a repayment demand for six-figure tuition costs — will be awarded their degrees, officials said Saturday.
Following a “standard review” of graduation requirements for this year’s senior class, the Academy’s board recommended awarding Bachelor of Science degrees “for the three cadets refusing the COVID-19 vaccine,” a press release from the Colorado Springs, Colorado, school said.
However, the Academy stated, “they will not be commissioned into the United States Air Force as long as they remain unvaccinated,” and Air Force Secretary Frank Kendall will decide whether the graduates must “reimburse the United States for education costs in lieu of service.”
According to attorney Mike Rose, the unvaccinated cadets will not be allowed to attend the graduation ceremony.
“That has been confirmed and is petty, vindictive, disrespectful and unnecessary,” Mr. Rose, who represents unvaccinated cadet Jameson Barnard, said via email. --->READ MORE HERE
Follow links below to relevant/related stories and resources:

Virus surges again, but the era of sweeping COVID-19 mandates may be over

North Korea’s COVID tally nears 2 million a week after it acknowledged first ever case

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.


No comments: